share_log

港股异动 | 天齐锂业(09696)再涨超5% 泰利森第三期化学级锂精矿扩产项目干法区已接近完成

Stocks in Hong Kong surged again, tianqi lithium corporation (09696) rose by over 5%. The third phase expansion project of the chemical-grade lithium concentrate at Talison is nearing completion.

Zhitong Finance ·  11:47

Tianqi Lithium Corporation (09696) continued to rise, as of the time of publication, it increased by 4.99%, closing at 27.35 Hong Kong dollars, with a turnover of 54.834 million Hong Kong dollars.

According to the Wisdom Finance APP, Tianqi Lithium Corporation (09696) continued to rise, as of the time of publication, it increased by 4.99%, closing at 27.35 Hong Kong dollars, with a turnover of 54.834 million Hong Kong dollars.

On the news front, recently, Tianqi Lithium Corporation stated at an analyst conference that as of now, the construction of the dry area of the third phase of Talison's chemical-grade lithium concentrate expansion project is nearing completion, while the wet area's structural steel installation is in progress, followed by machinery, pipeline, and other installation works. The project is expected to produce the first batch of lithium concentrate products in the fourth quarter of 2025. Regarding the specific commissioning time, the company will comprehensively evaluate various factors. As a reference, Talison's CGP2 and TRP projects took approximately one year for commissioning.

Previously, Tianqi Lithium Corporation announced that from July to October 2024, after reviewing the project budget and progress, the board of directors of Wensfield intends to adjust the overall budget for Talison's third phase of chemical-grade lithium concentrate expansion project to 0.8813 billion Australian dollars.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment